Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind CEO said it's because Meta is behind in the AI race. The AI talent war is raising concerns about increasing ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...

The lab is led by Mustafa Suleyman, who co-founded DeepMind before Google acquired it in 2014 and only left the company in ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Microsoft has hired more than 20 artificial intelligence pros from Google’s DeepMind unit in the past six months, ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that predicts what effects small changes in DNA will have on an array of molecular ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

Google on Thursday announced the second cohort to take part in its AI Academy: American Infrastructure, which seeks to ...